The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Alkaline Phosphatase, subunit A
".
FunFam 3: Extracellular sulfatase
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 8 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Arylsulfatase activity GO:0004065
Catalysis of the reaction: a phenol sulfate + H2O = a phenol + sulfate.
|
20 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(10 more) |
N-acetylglucosamine-6-sulfatase activity GO:0008449
Catalysis of the hydrolysis of the 6-sulfate group of the N-acetyl-D-glucosamine 6-sulfate units of heparan sulfate and keratan sulfate.
|
17 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(7 more) |
N-acetylglucosamine-6-sulfatase activity GO:0008449
Catalysis of the hydrolysis of the 6-sulfate group of the N-acetyl-D-glucosamine 6-sulfate units of heparan sulfate and keratan sulfate.
|
5 | Q8CFG0 (/IMP) Q8IWU5 (/IMP) Q8IWU6 (/IMP) Q8IWU6 (/IMP) Q8K007 (/IMP) |
N-acetylglucosamine-6-sulfatase activity GO:0008449
Catalysis of the hydrolysis of the 6-sulfate group of the N-acetyl-D-glucosamine 6-sulfate units of heparan sulfate and keratan sulfate.
|
4 | Q8IWU5 (/IDA) Q8IWU6 (/IDA) Q8IWU6 (/IDA) Q90XB6 (/IDA) |
Arylsulfatase activity GO:0004065
Catalysis of the reaction: a phenol sulfate + H2O = a phenol + sulfate.
|
3 | Q8IWU5 (/IDA) Q8IWU6 (/IDA) Q8IWU6 (/IDA) |
Arylsulfatase activity GO:0004065
Catalysis of the reaction: a phenol sulfate + H2O = a phenol + sulfate.
|
3 | Q8IWU5 (/IMP) Q8IWU6 (/IMP) Q8IWU6 (/IMP) |
Arylsulfatase activity GO:0004065
Catalysis of the reaction: a phenol sulfate + H2O = a phenol + sulfate.
|
2 | Q8CFG0 (/ISO) Q8K007 (/ISO) |
N-acetylglucosamine-6-sulfatase activity GO:0008449
Catalysis of the hydrolysis of the 6-sulfate group of the N-acetyl-D-glucosamine 6-sulfate units of heparan sulfate and keratan sulfate.
|
2 | Q8CFG0 (/ISO) Q8K007 (/ISO) |
There are 76 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
21 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(11 more) |
Chondrocyte development GO:0002063
The process whose specific outcome is the progression of a chondrocyte over time, from its commitment to its mature state. Chondrocyte development does not include the steps involved in committing a chondroblast to a chondrocyte fate.
|
21 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(11 more) |
Esophagus smooth muscle contraction GO:0014846
A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. This process occurs in the esophagus. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. The esophagus is the muscular membranous segment between the pharynx and the stomach in the upper gastrointestinal tract.
|
21 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(11 more) |
Glial cell-derived neurotrophic factor receptor signaling pathway GO:0035860
The series of molecular signals generated as a consequence of a glial cell-derived neurotrophic factor receptor binding to one of its physiological ligands.
|
21 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(11 more) |
Negative regulation of fibroblast growth factor receptor signaling pathway GO:0040037
Any process that stops, prevents, or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity.
|
21 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(11 more) |
Embryonic skeletal system development GO:0048706
The process, occurring during the embryonic phase, whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure.
|
21 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(11 more) |
Cartilage development GO:0051216
The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
21 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(11 more) |
Bone development GO:0060348
The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components.
|
21 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(11 more) |
Innervation GO:0060384
The process in which a nerve invades a tissue and makes functional synaptic connection within the tissue.
|
21 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(11 more) |
Negative regulation of prostatic bud formation GO:0060686
Any process that decreases the rate, frequency, or extent of prostatic bud formation, the morphogenetic process in which a region of the fetal urogenital sinus epithelium is specified to become the prostate, resulting in prostate bud outgrowth.
|
20 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(10 more) |
Negative regulation of endothelial cell proliferation GO:0001937
Any process that stops, prevents, or reduces the rate or extent of endothelial cell proliferation.
|
19 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(9 more) |
Negative regulation of angiogenesis GO:0016525
Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
|
19 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(9 more) |
Positive regulation of Wnt signaling pathway GO:0030177
Any process that activates or increases the frequency, rate or extent of Wnt signal transduction.
|
19 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(9 more) |
Negative regulation of cell migration GO:0030336
Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.
|
19 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(9 more) |
Positive regulation of BMP signaling pathway GO:0030513
Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
|
19 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(9 more) |
Vascular endothelial growth factor receptor signaling pathway GO:0048010
Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
19 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(9 more) |
Cartilage condensation GO:0001502
The condensation of mesenchymal cells that have been committed to differentiate into chondrocytes.
|
18 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(8 more) |
Cell adhesion GO:0007155
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
|
18 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(8 more) |
Limb joint morphogenesis GO:0036022
The process in which the anatomical structures of a limb joint are generated and organized. A limb joint is a flexible region that separates the rigid sections of a limb to allow movement in a controlled manner.
|
18 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(8 more) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
18 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(8 more) |
Heparan sulfate proteoglycan metabolic process GO:0030201
The chemical reactions and pathways involving any proteoglycan containing heparan sulfate, any member of a group of glycosaminoglycans that have repeat units consisting of alternating alpha-(1->4)-linked hexuronic acid and glucosamine residues, the former being a mixture of sulfated and nonsulfated D-glucuronic and L-iduronic acids, and the latter being either sulfated or acetylated on its amino group as well as sulfated on one of its hydroxyl groups.
|
17 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(7 more) |
Vasculogenesis GO:0001570
The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
|
4 | F6P5J8 (/IMP) Q6EF99 (/IMP) Q6EFA0 (/IMP) Q6EFA1 (/IMP) |
Somitogenesis GO:0001756
The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
|
4 | F6P5J8 (/IMP) Q6EF99 (/IMP) Q6EFA0 (/IMP) Q6EFA1 (/IMP) |
Vasculature development GO:0001944
The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
|
4 | F6P5J8 (/IMP) Q6EF99 (/IMP) Q6EFA0 (/IMP) Q6EFA1 (/IMP) |
Blood circulation GO:0008015
The flow of blood through the body of an animal, enabling the transport of nutrients to the tissues and the removal of waste products.
|
4 | F6P5J8 (/IMP) Q6EF99 (/IMP) Q6EFA0 (/IMP) Q6EFA1 (/IMP) |
Smoothened signaling pathway involved in ventral spinal cord patterning GO:0021910
The series of molecular signals generated as a consequence of activation of the transmembrane protein Smoothened that results in the spatial identity of regions along the dorsal-ventral axis of the spinal cord.
|
4 | F6P5J8 (/IMP) Q6EF99 (/IMP) Q6EFA0 (/IMP) Q6EFA1 (/IMP) |
Heparan sulfate proteoglycan metabolic process GO:0030201
The chemical reactions and pathways involving any proteoglycan containing heparan sulfate, any member of a group of glycosaminoglycans that have repeat units consisting of alternating alpha-(1->4)-linked hexuronic acid and glucosamine residues, the former being a mixture of sulfated and nonsulfated D-glucuronic and L-iduronic acids, and the latter being either sulfated or acetylated on its amino group as well as sulfated on one of its hydroxyl groups.
|
4 | Q8IWU5 (/IDA) Q8IWU6 (/IDA) Q8IWU6 (/IDA) Q90XB6 (/IDA) |
Regulation of developmental pigmentation GO:0048070
Any process that modulates the frequency, rate or extent of the developmental process that results in the deposition of coloring matter in an organism.
|
4 | F6P5J8 (/IMP) Q6EF99 (/IMP) Q6EFA0 (/IMP) Q6EFA1 (/IMP) |
Neuromast deposition GO:0048885
The process in which a migrating neuromast primordium deposits clusters of undifferentiated cells (proneuromasts) along its migratory path in a developing lateral line.
|
4 | F6P5J8 (/IMP) Q6EF99 (/IMP) Q6EFA0 (/IMP) Q6EFA1 (/IMP) |
Regulation of myotome development GO:2000290
Any process that modulates the frequency, rate or extent of myotome development.
|
4 | F6P5J8 (/IMP) Q6EF99 (/IMP) Q6EFA0 (/IMP) Q6EFA1 (/IMP) |
Glomerular filtration GO:0003094
The process in which plasma is filtered through the glomerular membrane which consists of capillary endothelial cells, the basement membrane, and epithelial cells. The glomerular filtrate is the same as plasma except it has no significant amount of protein.
|
3 | Q8IWU5 (/ISS) Q8IWU6 (/ISS) Q8IWU6 (/ISS) |
Positive regulation of vascular endothelial growth factor production GO:0010575
Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.
|
3 | Q8IWU5 (/ISS) Q8IWU6 (/ISS) Q8IWU6 (/ISS) |
Positive regulation of Wnt signaling pathway GO:0030177
Any process that activates or increases the frequency, rate or extent of Wnt signal transduction.
|
3 | Q8IWU5 (/IDA) Q8IWU6 (/IDA) Q8IWU6 (/IDA) |
Heparan sulfate proteoglycan metabolic process GO:0030201
The chemical reactions and pathways involving any proteoglycan containing heparan sulfate, any member of a group of glycosaminoglycans that have repeat units consisting of alternating alpha-(1->4)-linked hexuronic acid and glucosamine residues, the former being a mixture of sulfated and nonsulfated D-glucuronic and L-iduronic acids, and the latter being either sulfated or acetylated on its amino group as well as sulfated on one of its hydroxyl groups.
|
3 | Q8IWU5 (/NAS) Q8IWU6 (/NAS) Q8IWU6 (/NAS) |
Glomerular basement membrane development GO:0032836
The process whose specific outcome is the progression of the glomerular basement membrane over time, from its formation to the mature structure. The glomerular basement membrane is the basal laminal portion of the glomerulus which performs the actual filtration.
|
3 | Q8IWU5 (/ISS) Q8IWU6 (/ISS) Q8IWU6 (/ISS) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
2 | Q8CFG0 (/IGI) Q8K007 (/IGI) |
Negative regulation of endothelial cell proliferation GO:0001937
Any process that stops, prevents, or reduces the rate or extent of endothelial cell proliferation.
|
2 | Q8IWU6 (/IDA) Q8IWU6 (/IDA) |
Chondrocyte development GO:0002063
The process whose specific outcome is the progression of a chondrocyte over time, from its commitment to its mature state. Chondrocyte development does not include the steps involved in committing a chondroblast to a chondrocyte fate.
|
2 | Q8CFG0 (/IMP) Q8K007 (/IMP) |
Glomerular filtration GO:0003094
The process in which plasma is filtered through the glomerular membrane which consists of capillary endothelial cells, the basement membrane, and epithelial cells. The glomerular filtrate is the same as plasma except it has no significant amount of protein.
|
2 | Q8CFG0 (/IGI) Q8K007 (/IGI) |
Sulfur compound metabolic process GO:0006790
The chemical reactions and pathways involving the nonmetallic element sulfur or compounds that contain sulfur, such as the amino acids methionine and cysteine or the tripeptide glutathione.
|
2 | Q8CFG0 (/ISO) Q8K007 (/ISO) |
Positive regulation of vascular endothelial growth factor production GO:0010575
Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.
|
2 | Q8CFG0 (/IGI) Q8K007 (/IGI) |
Esophagus smooth muscle contraction GO:0014846
A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. This process occurs in the esophagus. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. The esophagus is the muscular membranous segment between the pharynx and the stomach in the upper gastrointestinal tract.
|
2 | Q8CFG0 (/IGI) Q8K007 (/IGI) |
Negative regulation of angiogenesis GO:0016525
Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
|
2 | Q8IWU6 (/IDA) Q8IWU6 (/IDA) |
Positive regulation of Wnt signaling pathway GO:0030177
Any process that activates or increases the frequency, rate or extent of Wnt signal transduction.
|
2 | Q8CFG0 (/ISO) Q8K007 (/ISO) |
Heparan sulfate proteoglycan metabolic process GO:0030201
The chemical reactions and pathways involving any proteoglycan containing heparan sulfate, any member of a group of glycosaminoglycans that have repeat units consisting of alternating alpha-(1->4)-linked hexuronic acid and glucosamine residues, the former being a mixture of sulfated and nonsulfated D-glucuronic and L-iduronic acids, and the latter being either sulfated or acetylated on its amino group as well as sulfated on one of its hydroxyl groups.
|
2 | Q8CFG0 (/IMP) Q8K007 (/IMP) |
Heparan sulfate proteoglycan metabolic process GO:0030201
The chemical reactions and pathways involving any proteoglycan containing heparan sulfate, any member of a group of glycosaminoglycans that have repeat units consisting of alternating alpha-(1->4)-linked hexuronic acid and glucosamine residues, the former being a mixture of sulfated and nonsulfated D-glucuronic and L-iduronic acids, and the latter being either sulfated or acetylated on its amino group as well as sulfated on one of its hydroxyl groups.
|
2 | Q8CFG0 (/ISO) Q8K007 (/ISO) |
Negative regulation of cell migration GO:0030336
Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.
|
2 | Q8IWU6 (/IMP) Q8IWU6 (/IMP) |
Positive regulation of BMP signaling pathway GO:0030513
Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
|
2 | Q8IWU6 (/IMP) Q8IWU6 (/IMP) |
Glomerular basement membrane development GO:0032836
The process whose specific outcome is the progression of the glomerular basement membrane over time, from its formation to the mature structure. The glomerular basement membrane is the basal laminal portion of the glomerulus which performs the actual filtration.
|
2 | Q8CFG0 (/IGI) Q8K007 (/IGI) |
Glial cell-derived neurotrophic factor receptor signaling pathway GO:0035860
The series of molecular signals generated as a consequence of a glial cell-derived neurotrophic factor receptor binding to one of its physiological ligands.
|
2 | Q8CFG0 (/IDA) Q8K007 (/IDA) |
Regulation of fibroblast growth factor receptor signaling pathway GO:0040036
Any process that modulates the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity.
|
2 | Q8IWU6 (/IMP) Q8IWU6 (/IMP) |
Negative regulation of fibroblast growth factor receptor signaling pathway GO:0040037
Any process that stops, prevents, or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity.
|
2 | Q8CFG0 (/IGI) Q8K007 (/IGI) |
Negative regulation of fibroblast growth factor receptor signaling pathway GO:0040037
Any process that stops, prevents, or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity.
|
2 | Q8IWU6 (/IMP) Q8IWU6 (/IMP) |
Vascular endothelial growth factor receptor signaling pathway GO:0048010
Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | Q8IWU6 (/IDA) Q8IWU6 (/IDA) |
Embryonic skeletal system development GO:0048706
The process, occurring during the embryonic phase, whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure.
|
2 | Q8CFG0 (/IGI) Q8K007 (/IGI) |
Cartilage development GO:0051216
The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
2 | Q8CFG0 (/IMP) Q8K007 (/IMP) |
Bone development GO:0060348
The process whose specific outcome is the progression of bone over time, from its formation to the mature structure. Bone is the hard skeletal connective tissue consisting of both mineral and cellular components.
|
2 | Q8CFG0 (/IGI) Q8K007 (/IGI) |
Innervation GO:0060384
The process in which a nerve invades a tissue and makes functional synaptic connection within the tissue.
|
2 | Q8CFG0 (/IGI) Q8K007 (/IGI) |
Cartilage condensation GO:0001502
The condensation of mesenchymal cells that have been committed to differentiate into chondrocytes.
|
1 | Q90XB6 (/IDA) |
Negative regulation of endothelial cell proliferation GO:0001937
Any process that stops, prevents, or reduces the rate or extent of endothelial cell proliferation.
|
1 | Q8K007 (/ISO) |
Cell adhesion GO:0007155
The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
|
1 | Q90XB6 (/IDA) |
Response to wounding GO:0009611
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
|
1 | Q8CFG0 (/IMP) |
Negative regulation of angiogenesis GO:0016525
Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
|
1 | Q8K007 (/ISO) |
Negative regulation of cell migration GO:0030336
Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.
|
1 | Q8K007 (/ISO) |
Positive regulation of BMP signaling pathway GO:0030513
Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
|
1 | Q8K007 (/ISO) |
Limb joint morphogenesis GO:0036022
The process in which the anatomical structures of a limb joint are generated and organized. A limb joint is a flexible region that separates the rigid sections of a limb to allow movement in a controlled manner.
|
1 | Q90XB6 (/IDA) |
Regulation of fibroblast growth factor receptor signaling pathway GO:0040036
Any process that modulates the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity.
|
1 | Q8K007 (/ISO) |
Negative regulation of fibroblast growth factor receptor signaling pathway GO:0040037
Any process that stops, prevents, or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity.
|
1 | Q8K007 (/IDA) |
Negative regulation of fibroblast growth factor receptor signaling pathway GO:0040037
Any process that stops, prevents, or reduces the frequency, rate or extent of fibroblast growth factor receptor signaling pathway activity.
|
1 | Q8K007 (/ISO) |
Vascular endothelial growth factor receptor signaling pathway GO:0048010
Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | Q8K007 (/ISO) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
1 | Q90XB6 (/IDA) |
Negative regulation of prostatic bud formation GO:0060686
Any process that decreases the rate, frequency, or extent of prostatic bud formation, the morphogenetic process in which a region of the fetal urogenital sinus epithelium is specified to become the prostate, resulting in prostate bud outgrowth.
|
1 | Q8K007 (/IDA) |
Positive regulation of canonical Wnt signaling pathway GO:0090263
Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
1 | Q90XB6 (/IDA) |
Positive regulation of canonical Wnt signaling pathway GO:0090263
Any process that increases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
|
1 | Q8CFG0 (/IMP) |
Liver regeneration GO:0097421
The regrowth of lost or destroyed liver.
|
1 | Q8CFG0 (/IMP) |
Regulation of hepatocyte proliferation GO:2000345
Any process that modulates the frequency, rate or extent of hepatocyte proliferation.
|
1 | Q8CFG0 (/IMP) |
There are 19 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
20 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(10 more) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
20 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(10 more) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
19 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(9 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
18 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(8 more) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
17 |
A0A1D5PN22 (/ISS)
E1BGL6 (/ISS)
F1RU06 (/ISS)
F1RU06 (/ISS)
F6PP52 (/ISS)
F6VXY6 (/ISS)
F7DW81 (/ISS)
F7FJY3 (/ISS)
G1KQZ3 (/ISS)
G1LHX9 (/ISS)
(7 more) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
5 | Q8IWU5 (/IDA) Q8IWU6 (/IDA) Q8IWU6 (/IDA) Q8VI60 (/IDA) Q90XB6 (/IDA) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
5 | Q8IWU5 (/IDA) Q8IWU6 (/IDA) Q8IWU6 (/IDA) Q8VI60 (/IDA) Q90XB6 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
3 | Q8IWU6 (/IDA) Q8IWU6 (/IDA) Q90XB6 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
3 | Q8IWU5 (/NAS) Q8IWU6 (/NAS) Q8IWU6 (/NAS) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
3 | Q8IWU5 (/ISS) Q8IWU6 (/ISS) Q8IWU6 (/ISS) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | Q8IWU6 (/HDA) Q8IWU6 (/HDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | Q8CFG0 (/ISO) Q8K007 (/ISO) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
2 | Q8CFG0 (/ISO) Q8K007 (/ISO) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
2 | Q8CFG0 (/IDA) Q8K007 (/IDA) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
2 | Q8CFG0 (/ISO) Q8K007 (/ISO) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
2 | Q8IWU6 (/IDA) Q8IWU6 (/IDA) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
1 | Q8VI60 (/IDA) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
1 | Q8K007 (/ISO) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
1 | Q8K007 (/ISO) |